Sales rise 26.64% to Rs 161.44 crore
Net profit of Astrazeneca Pharma India rose 10.17% to Rs 6.39 crore in the quarter ended June 2018 as against Rs 5.80 crore during the previous quarter ended June 2017. Sales rose 26.64% to Rs 161.44 crore in the quarter ended June 2018 as against Rs 127.48 crore during the previous quarter ended June 2017. ParticularsQuarter EndedJun. 2018Jun. 2017% Var.Sales161.44127.48 27 OPM %5.744.89 -PBDT12.6910.88 17 PBT9.147.17 27 NP6.395.80 10Powered by Capital Market - Live News
(This story has not been edited by Business Standard staff and is auto-generated from a syndicated feed.)